Women facing HIV. Key question on women with hiv infection: Italian consensus workshop

Infection

Volumn 37, Issue 2, 2009, Pages 168-178

  Carosi, G ^a   Nasta, P ^a   Fiore, S ^b   Matteelli, A ^a   Cauda, R ^c   Ferrazzi, E ^b   Tamburrini, E ^c   Savasi, V ^b   Bini, T ^b   Ravizza, M ^b   Bucceri, A ^d   Vichi, F ^e   Murri, R ^c   Mazzotta, F ^e   D'Arminio Monforte, A ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d L Mangiagalli Hospital   (Italy)

^e SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; FAMCICLOVIR; FOSCARNET; LOPINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; VALACICLOVIR; ZALCITABINE; ZIDOVUDINE;

ANTIBIOTIC PROPHYLAXIS; BONE DENSITY; CESAREAN SECTION; CONFERENCE PAPER; CONSENSUS; COUNSELING; FETOMATERNAL TRANSFUSION; GASTROINTESTINAL SYMPTOM; GENITAL HERPES; GYNECOLOGIC DISEASE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEART INFARCTION; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; LIPOATROPHY; LIPODYSTROPHY; LIVER TOXICITY; MATERNAL CARE; MEDICAL SOCIETY; MEDICAL SPECIALIST; MITOCHONDRIAL TOXICITY; PATIENT COMPLIANCE; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL SCREENING; RASH; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; TERATOGENICITY; UTERINE CERVIX CANCER; VAGINA CANDIDIASIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ITALY; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCTIVE TECHNIQUES, ASSISTED; SEX CHARACTERISTICS; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH;

EID: 67349116479     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-7361-7     Document Type: Conference Paper

References (109)

1. Forum for Collaborative HIV Research. Sex and gender in HIV diseases. The George Washington University Medical Centre, Washington D.C., 2002, pp. 1-57.
2. Anonymus 1994 Special consideration regarding human immunodeficiency virus and assisted reproductive technologies Fertil Steril 62 [Suppl1] 85S
3. C.S. Hall J.D. Marrazzo 2007 Emerging issues in management of sexually transmitted diseases in HIV infection Curr Infect Dis Rep 9 518 530 (Pubitemid 350081432)
4. F.J. Palella Jr K.M. Delaney A.C. Moorman M.O. Loveless J. Fuhrer G.A. Satten D.J. Aschman S.D. Holmberg 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 853 860 (Pubitemid 28135961)
5. K.H. Mayer J.W. Hogan D. Smith R.S. Klein P. Schuman J.B. Margolick C. Korkontzelou H. Farzedegan D. Vlahov C.C. Carpenter 2003 HIV Epidemiology Research Study (HERS) Group: Clinical and immunologic progression in HIV infected US women before and after the introduction of highly active antiretroviral therapy J Acquir Immun Defic Syndr 33 614 624 (Pubitemid 36975850)
6. M. Prins L. Meyer N. Hessol 2005 Sex and the curse of HIV infection in the pre-highly active antiretroviral therapy eras AIDS 19 357 370 (Pubitemid 40446182)
7. Hessamfar-Bonarek M, Chene G, Cacuub P, Salomon D, May T, et al: Causes of death in HIV-infected women and their evolution since 2000: the mortalitè 2000 and 2005 surveys, ANRS EN19. In: 15th conference on retroviruses and opportunistic infection, February 3-6, 2008, Boston, MA, USA (Abstract 666).
8. R. Murri A.C. Lepri A.N. Phillips E. Girardi G. Nasti S. Ferrara M.S. Mura C. Mussini E. Petrelli M. Arlotti C. De Stefano P. Vigano R. Novati A. Cargnel A.D. Monforte 2003 I.Co.N.A. Study Group: Access to antiretroviral treatment, incidence of sustained therapy interruption and risk of clinical events according to sex evidence from I.Co.N.A Study Group J Acquir Immun Defic Syndr 34 184 190 (Pubitemid 37248915)
9. Department of Gender: Women and health (GWH) and department of HIV/AIDS in WHO and UNAIDS (2004): ensuring equitable access to antiretroviral treatment for women. Guidance on Ethics and Equitable access to HIV treatment and Care. WHO/UNAIDS, Geneva.
10. Aggiornametno dei casi AIDS notificati in Italia e delle nuove diagnosi di infezione da HIV al 31 dicembre 2006. Notiziario dell'Istituto Superiore di Sanità 2007; 20[Supp 1].
11. K.E. Squires 2007 Gender differences in the diagnosis and treatment of HIV Gend Med 4 294 307
12. T.R. Sterling D. Vlahov J. Astemborski D.R. Hoover J.B. Margolick T.C. Quinn 2001 Initial plasma HIV-1 RNA levels and progression to AIDS in women and men N Engl J Med 334 720 725 (Pubitemid 32204989)
13. C. Junghans B. Ledergerber P. Chan R. Weber M. Egger 1999 Sex differences in HIV-1 viral load and progression to AIDS. Swiss HIV Cohort Study Lancet 353 589 590 (Pubitemid 29078442)
14. Asin S, Heimberg A, Eszterhas S, Rollenhagen C, Howell A: Estradiol and progesterone regulate HIV-1 replication in peripheral blood mononuclear cells. In: Program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-6, 2008, Boston, MA, USA (Abstract 671).
15. A.L. Moore C.A. Sabin M.A. Johnson A.N. Phillips 2003 Gender and clinical outcomes after starting highly active antiretroviral therapy J Acquir Immune Defic Syndr 33 614 624
16. T.P. Giordano J.A. Wright M.Q. Hasan A.C. White Jr E.A. Graviss F. Visnegarwala 2003 Do sex and race/ethnicity influences CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? Clin Infect Dis 37 433 437 (Pubitemid 36976503)
17. M. Moroni 1999 Sex differences in HIV-1 viral load and progression to AIDS. I.Co.N.A Study Group Italian cohort of HIV-1 positive individuals Lancet 353 589 590
18. A. Mocroft M.J. Gill W. Davidson A.N. Phillips 2000 Are there differences in starting protease inhibitors, HAART and disease progression despite equal access to care? J Acquir Immune Def Syndr 24 475 482
19. E. Abel L. Painter 2003 Factors that influence adherence to HIV medications: perceptions of women and health care providers J Assoc Nurses AIDS Care 14 61 69 (Pubitemid 38552997)
20. M. Lazo S.J. Gange T.E. Wilson K. Anastos D.G. Ostrow M.D. Witt L.P. Jacobson 2007 Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women Clin Infect Dis 45 1377 1385
21. M.J. Silverberg M.E. Gore A.L. French M. Gandhi M.J. Glesby A. Kovacs T.E. Wilson M.A. Young S.J. Gange 2004 Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study Clin Infect Dis 39 717 724 (Pubitemid 39180446)
22. I. Ofotokun C. Pomeroy 2003 Sex differences in adverse reactions to antiretroviral drugs Top HIV Med 11 55 59
23. R.A. Clark 2005 Sex differences in antiretroviral therapy-associated intolerance and adverse events Drug Saf 28 1075 1083 (Pubitemid 41775999)
24. E.P. Acosta A. Bardeguez C.D. Zorrilla R. Van Dyke M.D. Hughes S. Huang L. Pompeo A.M. Stek J. Pitt D.H. Watts E. Smith E. Jimenez L. Mofenson 2004 Pediatric AIDS Clinical Trials Group 386 Protocol Team: Pharmacokinetics of saquinavir plus low dose ritonavir in human immunodeficiency virus in HV pregnant women Antimicrob Agents Chemother 48 430 436
25. M. Gandhi F. Aweeka R.M. Greenblatt T.F. Blaschke 2004 Sex differences in pharmacokinetics and pharmacodynamics of drugs Ann Rev Pharmacol Toxicol 44 499 523 (Pubitemid 38263851)
26. P.L. Anderson T.N. Kakuda S. Kawle C.V. Fletcher 2003 Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals AIDS 17 2159 2168 (Pubitemid 37338889)
27. L.M. Almond P.G. Hoggard D. Edirisinghe S.H. Khoo D.J. Back 2005 Intracellular and plasma pharmacokinetics of efavirenz in HIVinfected individuals J Antimicrob Chemother 56 738 744 (Pubitemid 41487777)
28. M. Pfister L. Labbé S.M. Hammer J. Mellors K.K. Bennett S. Rosenkranz L.B. Sheiner 2003 Adult AIDS Clinical Trial Group Study 398: Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398 Antimicrob Agents Chemother 47 130 137 (Pubitemid 36070353)
29. C.V. Fletcher H. Jiang R.C. Brundage E.P. Acosta R. Haubrich D. Katzenstein R.M. Gulick 2004 Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359 J Infect Dis 189 1176 1184 (Pubitemid 38457241)
30. Hitti J, Rosenkranz S, Cohn S, Kamemoto L, Kashuba A, Caten E, Aweeka F: Sex and weight as covariates in the pharmacokinetics of efavirenz, indinavir and nelfinavir. In: 11th conference on retroviruses and opportunistic infection, February 8-11, 2004, San Francisco, CA, USA (Abstract 604).
31. M.R. van der Leur D.M. Burger C.J. la Porte P.P. Koopmans 2006 A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults Ther Drug Monit 28 650 653 (Pubitemid 44564064)
32. R.A. Clark K. Theall 2004 Population-based study evaluating association between selected antiretroviral therapies and potential oral contraceptive pill failure J Acquir Immun Defic Syndr 37 1219 1220 (Pubitemid 39166660)
33. C. Mazhude S. Jones S. Murad C. Taylor P. Easterbrook 2002 Female sex but not ethnicity is a strong predictor of non nucleosides reverse transcriptase inhibitor-induced rash AIDS 16 1566 1568
34. K.H. Wong K.C. Chan S.S. Lee 2001 Sex differences in nevirapine rash Clin Infect Dis 33 2096 2098
35. F. van Leth S. Andrews B. Grinsztejn E. Wilkins M.K. Lazanas J.M. Lange J. Montaner 2005 2NN study group: The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART AIDS 19 463 471 (Pubitemid 40515849)
36. M. Galli F. Veglia G. Angarano S. Santambrogio E. Meneghini F. Gritti A. Cargnel F. Mazzotta A. Lazzarin 2003 Gender differences in antiretroviral drug related adipose tissue alterations. Women are at higher risk than man and develop particular lipodystrophy pattern J Acquir Immunedef Synd 24 58 61 (Pubitemid 37100112)
37. M.L. Sorli Redó H. Knobel Freud M. Montero C. Jericó Alba A. Guelar Grimberg J. Pedro-Botet Montoya 2007 Sex influence in lipodystrophy of HIV-infected patients and its association with cardiovascular risk factors AnMed Interna 24 168 172
38. N. Friis-Møller C.A. Sabin R. Weber A. d'Arminio Monforte W.M. El-Sadr P. Reiss R. Thiébaut L. Morfeldt S. De Wit C. Pradier G. Calvo M.G. Law O. Kirk A.N. Phillips J.D. Lundgren 2003 The Data Collection on Adverse Events of anti-HIV drugs (DAD) Study Group: Combination antiretroviral therapy and the risk of myocardial infarction N Engl J Med 349 1993 2003 (Pubitemid 37448922)
39. K. Anastos D. Lu O. Shi K. Mulligan P.C. Tien R. Freeman M.H. Cohen J. Justman N.A. Hessol 2007 The association of bone mineral density with HIV infection and antiretroviral treatment in women Antivir Ther 12 1049 1058 (Pubitemid 350114985)
40. C. Cazanave M. Dupon V. Lavignolle-Aurillac N. Barthe S. Lawson-Ayayi N. Mehsen P. Mercié P. Morlat R. Thiébaut F. Dabis 2008 Groupe d'Epidémiologie Clinique du SIDA en Aquitaine: Reduced bone mineral density in HIV-infected patients: prevalence and associated factors AIDS 22 395 402
41. S.E. Dolan J.S. Huang K.M. Killilea M.P. Sullivan N. Aliabadi S. Grinspoon 2004 Reduced bone density in HIV infected women AIDS 18 475 483 (Pubitemid 38365875)
42. European Collaborative Study: Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. 2005 Clin Infect Dis 40 458 465
43. N.L. Stanwood S.E. Cohn J.R. Heiser M. Pugliese 2007 Contraception and fertility plans in a cohort of HIV-positive women in care Contraception 75 294 298 (Pubitemid 46389617)
44. G.S. Ogilvie A. Palepu V.P. Remple E. Mann K. Heath G. MacDonald J. Christilaw J. Berkowitz W.A. Fisher D.R. Burdqe 2007 Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada AIDS 21 S83 S88
45. S. Walmsley 2003 Opt in- opt-out: what is the optimal for prenatal screening for HIV infection? Can Med Assoc J 168 707 708 (Pubitemid 36363667)
46. Perinatal HIV Guidelines Working Group: Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Available at: http://aidsinfo.nih.gov/Content-Files/ PerinatalGL.pdf . Accessed 8 May 2007.
47. E.M. Connor R.S. Sperling R. Gelber P. Kiselev G. Scott M.J. O'sullivan R. Van Dyke M. Bey W. Shearer R.L. Jacobson 1994 Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 331 1173 1180 (Pubitemid 24331334)
48. E.R. Cooper M. Charurat L. Mofenson I.C. Hanson J. Pitt C. Diaz K. Hayani S. Handelsman V. Smeriglio R. Hoff W. Blattner 2002 Women and Infants' Transmission Study Group: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission J Acquir Immune Defic Syndr 29 484 494 (Pubitemid 34456340)
49. A. Dorenbaum C.K. Cunningham R.D. Gelber M. Culnane L. Molfenson P. Britto C. Rekacewicz M.L. Newell J.F. Delfraissy B. Cunningham-Schrader M. Mirochnick J.L. Sullivan 2002 International PACTG 316 Team: Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial JAMA 288 189 198 (Pubitemid 34755279)
50. J.P. Ioannidis E.J. Abrams A. Ammann M. Bulterys J.J. Goedert L. Gray B.T. Korber M.J. Mayaux L.M. Mofenson M.L. Newell D.E. Shapiro J.P. Teglas C.M. Wilfert 2001 Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads < 1000 copies/ml J Infect Dis 183 539 545 (Pubitemid 32147509)
51. U.S. Department of Health and Human Services: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentsGL.pdf . Accessed 8 May 2007.
52. R.E. Tuomala D.H. Watts D. Li M. Vajaranant J. Pitt H. Hammill S. Landesman C. Zorrilla B. Thompson 2005 Women and Infants Transmission Study: Improved obstetrics outcomes and few maternal toxicities are associated with antiretroviral therapy including highly active antiretroviral therapy during pregnancy J Acquir Immun Defic Syndr 38 449 473 (Pubitemid 40381556)
53. M. Mirochinick E. Capparelli 2004 Pharmacokinetics of antiretrovirals in pregnant women Clin Pharmacokinet 43 1071 1087 (Pubitemid 40013177)
54. J.F.J.B. Nelle I. Schiollevoort 2004 Wit FWNM: Nelfinavir plasma concentrations are low during pregnancy Clin Infect Dis 39 736 740 (Pubitemid 39180449)
55. Peytavin G, Pierre-Francois S, Cassard B, de Truchis P, Winter C, Visseaux B, Damond F, Tubiana R, Mandelbrot L, Matheron S: Reduced lopinavir exposure during pregnancy: a case control study. In: Program and abstracts of the 14th conference on retroviruses and opportunistic infections; February 25-28, 2007, Los Angeles, California (Abstract 579).
56. van der Lugt J, Autar S, Ubolyam S, Cooper D, Lamge J, Phanuphak P, Burger D, Fernandez Garcia E, Wit F, Ruxrungtham K: Pharmacokinetics and pharmacodynamics of double boosted PI regimen of Saquinavir and Lopinavir/ritonavir in treatment naïve HIV-1 infected adults. In: Program and abstracts of the 14th conference on retroviruses and opportunistic infections, February 25-28, 2007, Los Angeles, California (Abstract 578).
57. Burger D, Egginnk A, Van der Ende I, Hawkins D, Vogel M, Fatkenheuer, Molto J, Richter C, Koopmans P, Schutz M; The SARA Study Group: The pharmacokinetics of saquinavir in new tablet formulation + Ritonavir (1000/100 mg twice daily) in HIV-1 infected pregnant women. In: Program and abstracts of the 14th conference on retroviruses and opportunistic infections, February 25-28, 2007, Los Angeles, California (Abstract 741).
58. D. Ripamonti D. Cattaneo F. Maggiolo M. Airoldi L. Frigerio P. Bertuletti M. Ruggeri G. Remuzzi F. Suter 2007 Atazanavir plus lowdose ritonavir in pregnancy: pharmacokinetics and placental transfer AIDS 21 2409 2415 (Pubitemid 350145172)
59. Bonora S, Gonzales de Requena D, Chiesa E, Maccabruni A, Forleo M, Vichi F, Fiore S, Bini T, Ferrazzi E, d'Arminio Monforte A, TARGET Study Group: Transplacental passage of Tenofovir and other ARVs at delivery. In: Program and abstracts of the 14th conference on retroviruses and opportunistic infections, February 25-28, 2007, Los Angeles, California (Abstract 738a).
60. Burchett S, Best B, Mirochinick M, Hu C, Capparelli E, Fletcher C, Smith E, Sheran B, Read J, Stek A for the PACTG P1026 Team: Tenofovir pharmacokinetics during pregnancy at delivery and postpartum. In: Program and abstracts of 14th conference on retroviruses and opportunistic infections, February 25-28, 2007, Los Angeles, California (Abstract 738b).
61. Hirt D, Urien S, Rey E, Arrive E, Avit D, Gray G, Nerrienet E, Ekouevi D, Dabis F, Treluyer JM: Population pharmacokinetics of emtricitabine in HIV-infected pregnant women and their neonates. In: TEmAA ANRS 12109 program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-6, 2008, Boston, MA (Abstract 626).
62. Haberel A, Linde R, Reitter A, Gute P, Knecht G, Mosh M, Lennemann T, Nisius G, Stephan C, Staszewski S: Safety and efficacy of tenofovir in pregnant women. In: Program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-6, 2008, Boston, MA (Abstract 627a).
63. Pichault MB, Jullien V, Azria E, Pannier E, Firtion G, Krivine A, Compagnucci A, Taulera O, Lanuay O, Treluyer JM, EA3620: Lopinavir population pharmacokinetics on HIV-infected pregnant women. In: Program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-6, 2008, Boston, MA (Abstract 628).
64. Cressey T, Van Dyke R, Jourdain G, Puthanakit T, Roongpisuthipong A, Achalapong J, Yuthavisuthi P, Prommas S, Chotivanich N, Mirochinick M; IMPAACT P1032 Team: Early postpartum pharmacokinetics of lopinavir when initiated intrapartum in Thai women: A substudy of the IMPAACT P1032 trial. In: Program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-6, 2008, Boston, MA (Abstract 630).
65. P.E. Sax R. Islam R.P. Walensky E. Losina M.C. Weinstein S.J. Goldie S.N. Sadownik K.A. Freedberg 2005 Should resistance testing be performed for treatment naïve HIV infected patients. A cost effective analysis Clin Infect Dis 41 1316 1323 (Pubitemid 41532676)
66. G. Birkus M.J. Hitchcock T. Cihlar 2002 Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors Antimicrob Agents Chemother 46 716 723 (Pubitemid 34157656)
67. L. Sarner A. Fakoya 2002 Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication Sex Transm Infect 78 58 59 (Pubitemid 34206317)
68. J. Hitti L.M. Frenkel A.M. Stek S.A. Nacman D. Baker A. Gonzales-Garcia A. Provisor E.M. Thorpe M.E. Paul M. Foca J. Gandia S. Huang L.Y. Wei L.M. Stevens D.H. Watts J. McNamara 2004 PACTG 1022 Study Team: Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022 J Acquir Immune Defic Syndr 36 772 776 (Pubitemid 38859341)
69. A.M. Cotter A.G. Garcia M.L. Duthely B. Luke M.J. O'sullivan 2006 Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis 193 1195 1201
70. C. Arvieux O. Tribut 2005 Amprenavir or fosamprenavir plus ritonavir: pharmacology, efficacy and tolerability profile Drugs 65 633 659 (Pubitemid 40477784)
71. The International Perinatal HIV Group 1999 The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1-a meta-analysis of 15 prospective cohort studies N Engl J Med 340 977 987 (Pubitemid 29157629)
72. Read JS, Newell ML: Efficacy and safety of cesarian delivery for prevention of mother to child transmission of HIV-1 (review). Cochrane Data Base Syst Rev 2005; 4 (Art No.):CD005479.
73. J. Louis M.B. Landon R.J. Gersnoviez K.J. Leveno C.Y. Spong D.J. Rouse A.H. Moawad M.W. Varner S.N. Caritis M. Harper R.J. Wapner M. Miodovnik M. Carpenter A.M. Peaceman M.J. O'sullivan B.M. Sibai O. Langer J.M. Thorp S.M. Ramin B.M. Mercer 2007 Maternal-Fetal Medicine Units Network, National Institute of Child Health and Human Development: Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery Obstet Gynecol 110 385 390
74. J. Louis M.A. Buhari D. Allen B. Gonik T.B. Jones 2006 Postpartum morbidity associated with advanced HIV disease Infect Dis Obstet Gynecol 2006 79512
75. H.M. Sebitloane J. Moodley T.M. Esterhuizen 2008 Prophylactic antibiotics for the prevention of postpartum infectious morbidity in women infected with human immunodeficiency virus: a randomized controlled trial Am J Obstet Gynecol 198 189
76. J.Y. Phelps 2007 Restricting access of human immunodeficiency virus (HIV)-seropositive patients to infertility services: a legal analysis of the rights of reproductive endocrinologists and of HIV-seropositive patients Fertil Steril 88 1483 1490 (Pubitemid 350216869)
77. J. Klein J.E. Pena M.H. Thorton M.V. Sauer 2003 Understanding the motivations, concerns and desires of human immunodeficiency virus 1 serodiscordant couples wishing to have children through assisted reproduction Obstet Gynecol 101 987 994 (Pubitemid 36561266)
78. A.C. Thornton F. Romanelli J.D. Collins 2004 Reproduction decision making for couples affected by HIV: a review of the literature Top HIV Med 12 61 67
79. R. Henrion L. Mandelbrot G. Firtion N. Crémieux E. Henrion-Géant 1993 HIV seropositivity and desire for children Contracept Fertil Sex 21 217 221
80. T. Zutlevics 2006 Should ART be offered to HIV-serodiscordant and HIV-seroconcordant couples: an ethical discussion? Hum Rec 21 1956 1960 (Pubitemid 44288065)
81. A. van der Straten C.A. Gómez J. Saul J. Quan N. Padian 2000 Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy AIDS 14 F47 F54 (Pubitemid 30182456)
82. Partisani M, Ohl J, Demangeat C, Binder-Foucard F, Nisand J, Lang JM: Premature ovarian deficiency in HIV infected women. In: Program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-6, 2008, Boston, MA (Abstract 669).
83. S. Grinspoon C. Corcoran T. Stanley J. Rabe S. Wilkie 2001 Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome J Clin Endocrinol Metab 86 4120 4126 (Pubitemid 32848523)
84. L. Waters C. Gilling-Smith F. Boag 2007 HIV infection and subfertility Int J STD AIDS 18 1 6 (Pubitemid 46310245)
85. O. Coll M. Lopez R. Vidal F. Figueras A. Suy S. Hernandez M. Loncà M. Palacio E. Martinez V. Vernaeve 2007 Fertility assessment in non-infertile HIV-infected women and their partners Reprod Biomed Online 14 488 494 (Pubitemid 46584385)
86. L.C. Frodsham F. Boag S. Barton C. Gilling-Smith 2005 Human immunodeficiency virus infection and fertility care in the UK: demand and supply Fertil Steril 85 285 289
87. J.Y. Fitch C. Stine W.D. Hager J. Mann M.B. Adam J. McIlhaney 2002 Condom effectiveness: factors that influence risk reduction Sex Transm Dis 29 811 817 (Pubitemid 35425312)
88. M.V. Sauer J. Choi 2006 HIV seroconversion in a women preparing for assisted reproduction: an inherent risk in caring for HIV-serodiscordant couple Reprod Biomed Online 12 375 377
89. American Society for reproductive Medicine, Birmingham, Alabama. 2002 Ethics Committee of the American Society for reproductive Medicine: Human immunodeficiency virus and infertility treatment Fertil Steril 77 218 222
90. L. Bujan L. Hollander M. Coudert C. Gilling-Smith A. Vucetich J. Guibert P. Vernazza J. Ohl M. Weigel Y. Englert A.E. Semprini 2007 CREAThE network: Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network AIDS 21 1909 1914 (Pubitemid 47329767)
91. V. Savasi E. Ferrazzi C. Lanzani M. Oneta B. Parrilla T. Persico 2007 Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couplet Hum Reprod 22 772 777
92. J. Ohl M. Partisani C. Wittemer M.P. Schmitt C. Cranz F. Stoll-Keller C. Rongieres K. Bettahar-Lebugle J.M. Lang I. Nisand 2003 Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience Hum Reprod 18 11244 11249 (Pubitemid 36740571)
93. L. Mencaglia P. Falcone G.M. Lentini S. Consigli M. Pisoni V. Lofiego R. Guidetti P. Piomboni V. De Leo 2005 ICSI for treatment of human immunodeficiency virus and hepatitis C virus-serodiscordant couples with infected male partner Hum Reprod 20 2242 2246 (Pubitemid 41418513)
94. P. Lebray 2007 Assisted reproductive techniques in hepatitis B or C infection: role of hepatologist Gynecol Obstet Fertile 35 1025 1029
95. E.M. Jonson 1990 The effect of ribavirin on development and reproduction: a critical review of published and unpublished studies in experimental animals J Am Coll Toxicol 9 551 561
96. M.S. Cohen 2007 Preventing sexual transmission of HIV Clin Infect Dis 45 S287 S292
97. Spencer L, Karim R, Landay A, Mack W, Stiller T: Association between Immune activation and HIV-RNA 1 genital shedding. In: Program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-7, 2008, Boston, MA (Abstract 674).
98. Wang CC, Liu T, Anderson B, De Long A, Chapman S: Association between genital tract HIV-1 RNA shedding and mucosal inflammation among women on effective ART with undetectable plasma viral load. In: Program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-7, 2008, Boston, MA (Abstract 675).
99. Baetan J, Strick L, Lucchetti A, Whittington W, Sanchez J: Herpes simplex virus suppressive treatment decrease plasma and genital HIV-1 viral loads in HSV-2/HIV-1 co-infected women: a randomized placebo controlled cross over trial. In: Program and abstracts of 15th conference on retroviruses and opportunistic infections, February 3-7, 2008, Boston, MA (Abstract 676).
100. Y. Gilleece A. Sullvann 2005 Management of sexually transmitted infections in HIV positive individuals Curr Opin Infect Dis 18 43 47 (Pubitemid 41716239)
101. J.D. Marrazzo 2007 Syphilis and other sexually transmitted diseases in HIV infection Top HIV Med 15 11 16
102. H.F. Robenau H.W. Doerr 2008 Genital herpes and HSV transmission in HIV patients Hautarz 59 11 17
103. Herpes treatment can help co-infected HIV patients. 2007 Research suggests herpes infection increases risk of HIV infection AIDS Alert 22 88 89
104. L. Corey N. Boodsworth A. Mindel R. Patel T. Shacker L. Stamberry 2007 An update on short-course episodic and prevention therapies for herpes genitalis Herpes 14 5A 11A (Pubitemid 47233676)
105. R. Gupta T. Warren A. Wald 2007 Genital herpes Lancet 370 2127 2137 (Pubitemid 350296304)
106. V. Martinez E. Caumes O. Chosidow 2008 Treatment to prevent current genital herpes Curr Opinion Infect Dis 21 42 48
107. J. Palefsky 2007 Human papilloma virus infection in HIV-infected persons Top HIV Med 15 130 133
108. I. Etienney S. Vuong F. Danile B. Mory M. Taouk S. Sultan C. Thomas J. Bourguignon V. de Parades N. Meary A. Balaton P. Atienza P. Bauer 2008 Prevalence of anal cytologic abnormalities in a French referral popoulation: a prospective study with special emphasis on HIV, HPV and smoking Dis Colum Rectum 51 67 72
109. L. Abramowitz D. Benabderrahmane P. Ravaud F. Walker C. Riuox C. Jestin E. Bouvet J.C. Soulè C. Leport X. Duval 2007 Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women prevalence and associated factors AIDS 21 1457 1465 (Pubitemid 46988006)